Complications following biopsy of an intraabdominal or retroperitoneal mass compared with a renal mass.

IF 1 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

Danish medical journal Pub Date : 2024-08-16 DOI:10.61409/A12230777

Katrine Schou-Jensen, Gry Christensen Medonos, Mette Christine Hochheim, Mark James Dusgaard McCullagh, Frederik Ferløv Thomsen

{"title":"Complications following biopsy of an intraabdominal or retroperitoneal mass compared with a renal mass.","authors":"Katrine Schou-Jensen, Gry Christensen Medonos, Mette Christine Hochheim, Mark James Dusgaard McCullagh, Frederik Ferløv Thomsen","doi":"10.61409/A12230777","DOIUrl":null,"url":null,"abstract":"Introduction: This study aimed to assess the short-term complication rate after US-guided core needle biopsies with an 18-gauge needle of retroperitoneal or intraabdominal masses (non-kidney group) compared with complications after biopsy from a renal mass (kidney group).Methods: This was a retrospective analysis of 330 consecutive patients in the non-kidney group and 330 control patients in the kidney group. We recorded baseline characteristics, diagnostic yield, complications graded as Clavien-Dindo (CD) and readmissions within one and seven days.Results: In all, 245 patients in the non-kidney and 281 patients in the kidney group had a biopsy performed. A total of 54 (22%) patients in the non-kidney group had a complication registered. However, 47 were minor complications (minor bleeding or localised pain, CD 1). In the kidney group, 47 (17%) patients had a complication, with 44 being graded as CD 1. No major complications (CD 3 or higher) were associated with the biopsies. Only 0.8% of patients in the non-kidney group and 0.7% in the kidney group had a treatment-requiring CD 2 complication (i.e. blood transfusion) directly caused by the US-guided biopsy. These complications were recognised less than 30 minutes or more than four hours after the procedure. We found no significant difference in the complication rate, diagnostic yield or risk of re-admission between the two groups.Conclusion: The observation period for patients who undergo an uncomplicated US-guided biopsy from an intraabdominal or retroperitoneal mass can safely be reduced to 30 minutes.Funding: None TRIAL REGISTRATION. Not relevant.","PeriodicalId":11119,"journal":{"name":"Danish medical journal","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Danish medical journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.61409/A12230777","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This study aimed to assess the short-term complication rate after US-guided core needle biopsies with an 18-gauge needle of retroperitoneal or intraabdominal masses (non-kidney group) compared with complications after biopsy from a renal mass (kidney group).

Methods: This was a retrospective analysis of 330 consecutive patients in the non-kidney group and 330 control patients in the kidney group. We recorded baseline characteristics, diagnostic yield, complications graded as Clavien-Dindo (CD) and readmissions within one and seven days.

Results: In all, 245 patients in the non-kidney and 281 patients in the kidney group had a biopsy performed. A total of 54 (22%) patients in the non-kidney group had a complication registered. However, 47 were minor complications (minor bleeding or localised pain, CD 1). In the kidney group, 47 (17%) patients had a complication, with 44 being graded as CD 1. No major complications (CD 3 or higher) were associated with the biopsies. Only 0.8% of patients in the non-kidney group and 0.7% in the kidney group had a treatment-requiring CD 2 complication (i.e. blood transfusion) directly caused by the US-guided biopsy. These complications were recognised less than 30 minutes or more than four hours after the procedure. We found no significant difference in the complication rate, diagnostic yield or risk of re-admission between the two groups.

Conclusion: The observation period for patients who undergo an uncomplicated US-guided biopsy from an intraabdominal or retroperitoneal mass can safely be reduced to 30 minutes.

Funding: None TRIAL REGISTRATION. Not relevant.

查看原文本刊更多论文

腹腔内或腹膜后肿块活检后的并发症与肾脏肿块活检后的并发症相比。

简介本研究旨在评估在美国引导下用18号针头对腹膜后或腹腔内肿块（非肾脏组）进行核心针活检后的短期并发症发生率，并与肾脏肿块（肾脏组）活检后的并发症发生率进行比较：这是一项回顾性分析，对象是非肾脏组的 330 名连续患者和肾脏组的 330 名对照组患者。我们记录了基线特征、诊断率、按克拉维恩-丁多（Clavien-Dindo，CD）分级的并发症以及1天和7天内的再入院情况：总共有 245 名非肾脏组患者和 281 名肾脏组患者进行了活组织切片检查。非肾脏组共有 54 名（22%）患者出现并发症。但其中 47 例为轻微并发症（轻微出血或局部疼痛，CD 1）。肾脏组有 47 名（17%）患者出现并发症，其中 44 例为 CD 1 级。活组织检查未出现重大并发症（CD 3 或更高）。在非肾脏组和肾脏组中，分别只有 0.8% 和 0.7% 的患者因 US 引导活检直接导致了需要治疗的 CD 2 并发症（即输血）。这些并发症都是在手术后不到 30 分钟或超过 4 小时后被发现的。我们发现两组患者在并发症发生率、诊断率或再次入院风险方面没有明显差异：结论：对腹腔内或腹膜后肿块进行无并发症的 US 引导活检的患者的观察时间可安全缩短至 30 分钟：无不相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Danish medical journal MEDICINE, GENERAL & INTERNAL-

CiteScore

2.30

自引率

6.20%

发文量

审稿时长

3-8 weeks

期刊介绍： The Danish Medical Journal (DMJ) is a general medical journal. The journal publish original research in English – conducted in or in relation to the Danish health-care system. When writing for the Danish Medical Journal please remember target audience which is the general reader. This means that the research area should be relevant to many readers and the paper should be presented in a way that most readers will understand the content. DMJ will publish the following articles: • Original articles • Protocol articles from large randomized clinical trials • Systematic reviews and meta-analyses • PhD theses from Danish faculties of health sciences • DMSc theses from Danish faculties of health sciences.